Legend Biotech Corporation

Founded in 2007, Catalent Pharma Solutions is one of the leading providers of advanced technologies to the pharmaceutical, biotechnology and consumer health industries in the world. It offers preclinical support, analytical, clinical manufacturing, packaging, regulatory consulting and drug delivery development services. The organization utilizes the GPEx technology, which provides a range of biologic cell line development services. It also features soft capsules under the Vegicaps and Zydis brands. Catalent Pharma Solutions offers a variety of pharmaceutical product development services. In addition, it produces biological products for preclinical and clinical studies. The organization's packaging solutions include DelPouch and DelStrip, which are unit-dose delivery systems for lotions, creams, ointments and thin film strips.

Impax Laboratories, Inc. is a pharmaceutical company that has faced legal challenges related to allegations of misleading investors about its business performance and conditions during a specified period. The litigation claims that the company engaged in collusive practices with industry peers to fix generic drug prices, impacting its sales and profitability. The case has involved various defendants, including company executives, and has resulted in significant stock price declines following public disclosures about the alleged misconduct. As part of a class action lawsuit, affected investors have been informed about their rights and potential eligibility for compensation from a settlement fund if approved by the court. Generated from the website

Mito Biopharm, LLC is a biopharmaceutical company based in Piscataway, NJ, specializing in the research and development of therapeutic solutions for non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. With a focus on addressing the continuum of NAFLD, from simple fat accumulation in the liver to more severe conditions like non-alcoholic steatohepatitis (NASH), Mito Biopharm aims to provide innovative treatments to prevent the progression of these diseases. Driven by cutting-edge technology and a dedicated team of experts, Mito Biopharm is committed to advancing drug discovery and developing a robust pipeline of potential therapies. With a strong emphasis on intellectual property, the company strives to make significant contributions to the field of biopharmaceuticals and improve the lives of patients affected by NAFLD and type 2 diabetes.Generated from the website